Treatment for Vitamin B12 Deficiency (Level <150 pg/mL)
For a patient with vitamin B12 level less than 150 pg/mL, initiate immediate treatment with intramuscular hydroxocobalamin 1 mg three times weekly for 2 weeks, followed by lifelong maintenance therapy of 1 mg every 2-3 months. 1, 2
Initial Treatment Protocol
Assess for Neurological Involvement First
If neurological symptoms are present (peripheral neuropathy, ataxia, cognitive impairment, gait disturbances):
- Administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs 1, 2
- Then transition to maintenance: 1 mg intramuscularly every 2 months for life 1, 2
If no neurological symptoms:
- Administer hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks 1, 2
- Then transition to maintenance: 1 mg intramuscularly every 2-3 months for life 1, 2
Alternative FDA-Approved Regimen (Cyanocobalamin)
The FDA label provides an alternative protocol using cyanocobalamin:
- 100 mcg daily for 6-7 days intramuscularly 3
- Then 100 mcg on alternate days for seven doses 3
- Then every 3-4 days for 2-3 weeks 3
- Followed by 100 mcg monthly for life 3
However, hydroxocobalamin is preferred over cyanocobalamin in patients with renal dysfunction, as cyanocobalamin requires renal clearance of the cyanide moiety and has been associated with increased cardiovascular events (hazard ratio 2.0) in diabetic nephropathy. 1, 4
Oral Alternative After Initial Loading
High-dose oral vitamin B12 (1000-2000 mcg daily) is therapeutically equivalent to intramuscular therapy for most patients, including those with malabsorption, and can be used after the initial loading phase if no neurological symptoms are present. 4, 2, 5, 6
Critical Pitfall to Avoid
Never administer folic acid before treating vitamin B12 deficiency, as it may mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord. 1, 4
Monitoring Strategy
- Check serum B12, homocysteine, and methylmalonic acid every 3 months until stabilization 1, 2
- Then monitor once yearly 1, 2
- Target homocysteine level <10 μmol/L for optimal outcomes 1
- Monitor for recurrent neurological symptoms and increase injection frequency if symptoms return 2
Special Considerations by Etiology
Post-bariatric surgery patients:
Ileal resection >20 cm:
Pernicious anemia:
- Lifelong parenteral therapy required; oral form is not dependable 3
Patients with renal dysfunction:
Route of Administration
Avoid the intravenous route entirely, as almost all vitamin will be lost in the urine. 3 Use intramuscular or deep subcutaneous injection. 3
Duration of Therapy
Treatment must continue for life when malabsorption is the cause. 2 Do not discontinue supplementation even if levels normalize, as patients will require lifelong therapy unless the underlying cause is surgically corrected (e.g., fish tapeworm expulsion, discontinuation of causative medications). 3